Exact Sciences Corporation (EXAS) Analyst Ratings - Stock Analysis

A list of analyst ratings for Exact Sciences (EXAS) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts.

CouponFollow Extension

$74
OFF

Cracking The Code: Understanding Analyst Reviews For Exact …

1 day from now

Sep 12, 2024 · Analysts have set 12-month price targets for Exact Sciences, revealing an average target of $74.0, a high estimate of $85.00, and a low estimate of $67.00.

nasdaq.com

$75.00
OFF

EXAS Reaffirms Stock Target, Rating Held On Amid CMS Price Boost

1 day from now

2 days ago · On Tuesday, Piper Sandler reaffirmed its Overweight rating and $75.00 stock price target for Exact Sciences (NASDAQ:EXAS) Corporation (NASDAQ:EXAS), a molecular …

investing.com

$70.00
OFF

Exact Sciences Stock Outlook Improves With Cologuard Plus Launch …

1 day from now

2 days ago · On Tuesday, Wolfe Research maintained a positive outlook on Exact Sciences (NASDAQ: EXAS), reiterating an Outperform rating and a $70.00 price target.The firm's …

investing.com

23%
OFF

Exact Sciences Stock Rating Maintained Outperform As Medicare …

1 day from now

2 days ago · Leerink Partners has reaffirmed its Outperform rating and $70.00 price target for Exact Sciences, anticipating the stock to rise following the recent 23% decline since the third …

investing.com

$75.00
OFF

Piper Sandler Releases A Buy Rating On Exact Sciences (EXAS)

1 day from now

2 days ago · Piper Sandler analyst David Westenberg assigned a Buy rating to Exact Sciences (EXAS – Research Report) today and set a price target of $75.00.The company’s shares …

businessinsider.com

$192
OFF

Why Is Exact Sciences Stock Trading Higher On Tuesday?

1 day from now

1 day ago · The analyst writes that reimbursement for Cologuard Plus will now be calculated based on two components: three times the fee for methylation analysis of Septin-9 ($192 x 3) …

yahoo.com

10%
OFF

Exact Sciences Stock Up 10%, BTIG Raises Target After 16% Price ...

1 day from now

2 days ago · Tuesday, BTIG raised the price target for Exact Sciences (NASDAQ: EXAS) to $75 from $65, maintaining a Buy rating on the stock.This adjustment follows the announcement …

investing.com

10%
OFF

Exact Sciences Stock Lifted By TD Cowen, Sees 10% Revenue Growth ...

1 day from now

2 days ago · On Tuesday, TD Cowen demonstrated a positive outlook for Exact Sciences Corp (NASDAQ: EXAS) by increasing the stock's price target from $82.00 to $86.00.The firm has …

investing.com

$75.00
OFF

Exact Sciences Gains Price Stability With Cologuard Plus Test Price ...

1 day from now

2 days ago · BTIG analyst Mark Massaro reiterated a Buy rating on Exact Sciences (EXAS – Research Report) today and set a price target of $75.00.Don't Miss o...

businessinsider.com

$192
OFF

Why Is Exact Sciences Stock Trading Higher On Monday?

1 day from now

1 day ago · The analyst writes that reimbursement for Cologuard Plus will now be calculated based on two components: three times the fee for methylation analysis of Septin-9 ($192 x 3) …

benzinga.com

16%
OFF

Exact Sciences Sees 16% Medicare Boost For Cologuard Plus Stock ...

1 day from now

2 days ago · Wolfe Research reiterated an Outperform rating for Exact Sciences, anticipating a significant impact on revenue from the launch of Cologuard Plus in late Q1 2025 or early Q2 …

investing.com

FAQs about Exact Sciences Corporation (EXAS) Analyst Ratings - Stock Analysis Coupon?

Should you buy Exact Sciences (Exact Sciences) stock?

The average target predicts an increase of 14.50% from the current stock price of 69.80. The average analyst rating for Exact Sciences stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market. ...

Should you buy Exact Sciences (EXAs)?

16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exact Sciences in the last twelve months. There is currently 1 hold rating and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EXAS shares. ...

What is the average price forecast for Exact Sciences stock?

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Exact Sciences is $80.64, with a high forecast of $95.00 and a low forecast of $67.00. Should I buy or sell Exact Sciences stock right now? ...

What is the average price target for Exact Sciences?

According to the 16 analysts' twelve-month price targets for Exact Sciences, the average price target is $80.64. The highest price target for EXAS is $95.00, while the lowest price target for EXAS is $67.00. The average price target represents a forecasted upside of 11.37% from the current price of $72.34. ...

How does exact sciences compare to other'medical' companies?

Analysts like Exact Sciences more than other "medical" companies. The consensus rating score for Exact Sciences is 2.94 while the average consensus rating score for "medical" companies is 2.79. Learn more on how EXAS compares to other companies. ...

Is exact sciences a good news company?

Exact Sciences has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies. ...